Format

Send to

Choose Destination
Biores Open Access. 2014 Apr 1;3(2):75-6. doi: 10.1089/biores.2014.0003.

Follow-up of implant survival comparing ficoll and bone marrow aspirate concentrate methods for hard tissue regeneration with mesenchymal stem cells in humans.

Author information

1
Department of Oral and Craniomaxillofacial Surgery, University Hospital Freiburg , Freiburg, Germany .

Abstract

OBJECTIVE:

Clinical follow-up of implant survival in 11 patients comparing two different methods for mesenchymal stem cell (MSC) isolation (Ficoll and bone marrow aspirate concentrate [BMAC]) applied in maxillary sinus augmentation.

METHODS:

Mononuclear cells, including MSCs, were concentrated with either Ficoll (control group, n=6 sinus) or BMAC (test group, n=12 sinus) and transplanted in combination with bovine bone mineral. A total of 50 implants were placed in a second surgical intervention (17 Ficoll/33 BMAC) and loaded after 4 months. Overall implant survival was assessed with a Kaplan-Meier model using package survival under R.

RESULTS:

Implant survival of the Ficoll group was 100% compared with the BMAC group, which had 93.4% survival (95% confidence interval, 0.849-1). The difference between the groups was not significant (p=0.381).

CONCLUSION:

The BMAC system is an effective and suitable "chair-side" method for clinical application in hard tissue regeneration.

KEYWORDS:

biomaterials; cell culture; tissue engineering

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center